Effectiveness and Costs of Enhanced Cocaine Treatments

This study has been completed.
Sponsor:
Information provided by:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT00167258
First received: September 9, 2005
Last updated: December 14, 2009
Last verified: December 2009
  Purpose

The study will evaluate the effectiveness, economic benefits, and costs of voucher reinforcement for cocaine and alcohol abstinence, additional counseling services, and their combination in a sample of cocaine dependent patients receiving outpatient treatment as usual in a community clinic.


Condition Intervention Phase
Cocaine Dependence
Behavioral: Voucher Reinforcement
Behavioral: Extra Counseling Services
Behavioral: Voucher Reinforcement + Extra Counseling Services
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Open Label
Primary Purpose: Treatment

Further study details as provided by University of Pennsylvania:

Estimated Study Completion Date: February 2007
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Enrollment in an intensive outpatient program (IOP) for no more than 1 month
  • Current DSM-IV diagnosis of cocaine dependence (month prior to IOP treatment)
  • 18-65 years of age
  • Ability to provide names of informants to help locate subject for follow-up

Exclusion Criteria:

  • IV heroin use in last year
  • Acute medical/psychiatric diagnosis that precludes outpatient treatment
  • Inpatient treatment for 6 weeks or more prior to IOP treatment
  • Incarceration for 6 months or more prior to IOP treatment
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00167258

Locations
United States, Pennsylvania
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Sponsors and Collaborators
University of Pennsylvania
Investigators
Principal Investigator: James R McKay, PhD University of Pennsylvania
  More Information

No publications provided

Responsible Party: Dr. James McKay, University of Pennsylvania
ClinicalTrials.gov Identifier: NCT00167258     History of Changes
Other Study ID Numbers: 702110
Study First Received: September 9, 2005
Last Updated: December 14, 2009
Health Authority: United States: Institutional Review Board
University of Pennsylvania: IRB
City of Philadelphia: IRB

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders

ClinicalTrials.gov processed this record on April 16, 2014